SCOTUS Upholds Access to Abortion Pill, Pharma Industry Applauds Court’s Ruling

Supreme Court_iStock, Mindaugas Dulinskas

Pictured: The U.S. Supreme Court building in Washington, DC/iStock, Mindaugas Dulinskas

The U.S. Supreme Court on Thursday unanimously rejected a challenge to the FDA’s approach to approving the abortion pill mifepristone, preserving wide access to the drug based on procedural grounds.


Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks

Advertise With Biotech Networks